Á. Ximénez-Carrillo
Autonomous University of Madrid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Á. Ximénez-Carrillo.
Stroke | 2015
Blanca Fuentes; María Alonso de Leciñana; Á. Ximénez-Carrillo; Patricia Martínez-Sánchez; Antonio Cruz-Culebras; Gustavo Zapata-Wainberg; Gerardo Ruiz-Ares; Remedios Frutos; Eduardo Fandiño; J.L. Caniego; Andrés Fernández-Prieto; Jose Carlos Méndez; Eduardo Bárcena; Begoña Marín; A. García-Pastor; Fernando Díaz-Otero; Antonio Gil-Núñez; J. Masjuan; J. Vivancos; Exuperio Díez-Tejedor
Background and Purpose— The complexity of endovascular revascularization treatment (ERT) in acute ischemic stroke and the small number of patients eligible for treatment justify the development of stroke center networks with interhospital patient transfers. However, this approach might result in futile transfers (ie, the transfer of patients who ultimately do not undergo ERT). Our aim was to analyze the frequency of these futile transfers and the reasons for discarding ERT and to identify the possible associated factors. Methods— We analyzed an observational prospective ERT registry from a stroke collaboration ERT network consisting of 3 hospitals. There were interhospital transfers from the first attending hospital to the on-call ERT center for the patients for whom this therapy was indicated, either primarily or after intravenous thrombolysis (drip and shift). Results— The ERT protocol was activated for 199 patients, 129 of whom underwent ERT (64.8%). A total of 120 (60.3%) patients required a hospital transfer, 50 of whom (41%) ultimately did not undergo ERT. There were no differences in their baseline characteristics, the times from stroke onset, or in the delays in interhospital transfers between the transferred patients who were treated and those who were not treated. The main reasons for rejecting ERT after the interhospital transfer were clinical improvement/arterial recanalization (48%) and neuroimaging criteria (32%). Conclusions— Forty-one percent of the ERT transfers were futile, but none of the baseline patient characteristics predicted this result. Futility could be reduced if repetition of unnecessary diagnostic tests was avoided.
European Journal of Neurology | 2012
B. Fuentes; P. Martínez-Sánchez; M. Alonso de Leciñana; J.A. Egido; G. Reig-Roselló; F. Díaz-Otero; V. Sánchez; P. Simal; Á. Ximénez-Carrillo; A. García-Pastor; Gerardo Ruiz-Ares; A. García-García; J. Masjuan; José Vivancos-Mora; A. Gil-Núñez; Exuperio Díez-Tejedor
To identify possible differences in the early response to intravenous thrombolysis (IVT) or in stroke outcome at 3 months, based on stroke subtype in patients with acute ischaemic stroke (IS).
European Journal of Neurology | 2016
M. Alonso de Leciñana; Blanca Fuentes; Á. Ximénez-Carrillo; J. Vivancos; Jaime Masjuan; Antonio Gil-Núñez; Patricia Martínez-Sánchez; Gustavo Zapata-Wainberg; Antonio Cruz-Culebras; A. García-Pastor; Fernando Díaz-Otero; Eduardo Fandiño; R. Frutos; J.L. Caniego; Jose Carlos Méndez; A. Fernández‐Prieto; E. Bárcena‐Ruiz; Exuperio Díez-Tejedor
The complexity and expense of endovascular treatment (EVT) for acute ischaemic stroke (AIS) can present difficulties in bringing this approach closer to the patients. A collaborative node was implemented involving three stroke centres (SCs) within the Madrid Stroke Network to provide round‐the‐clock access to EVT for AIS.
Journal of NeuroInterventional Surgery | 2017
María Alonso de Leciñana; Michal M Kawiorski; Á. Ximénez-Carrillo; Antonio Cruz-Culebras; A. García-Pastor; Patricia Martínez-Sánchez; Andrés Fernández-Prieto; J.L. Caniego; Jose Carlos Méndez; Gustavo Zapata-Wainberg; Alicia de Felipe-Mimbrera; Fernando Díaz-Otero; Gerardo Ruiz-Ares; R. Frutos; Eduardo Bárcena-Ruiz; Eduardo Fandiño; Begoña Marín; J. Vivancos; Jaime Masjuan; Antonio Gil-Núñez; Exuperio Díez-Tejedor; Blanca Fuentes
Background and purpose The benefits of mechanical thrombectomy (MT) in basilar artery occlusions (BAO) have not been explored in recent clinical trials. We compared outcomes and procedural complications of MT in BAO with anterior circulation occlusions. Methods Data from the Madrid Stroke Network multicenter prospective registry were analyzed, including baseline characteristics, procedure times, procedural complications, symptomatic intracranial hemorrhage (SICH), modified Rankin Scale (mRS), and mortality at 3 months. Results Of 479 patients treated with MT, 52 (11%) had BAO. The onset to reperfusion time lapse was longer in patients with BAO (median (IQR) 385 min (320–540) vs 315 min (240–415), p<0.001), as was the duration of the procedures (100 min (40–130) vs 60 min (39–90), p=0.006). Moreover, the recanalization rate was lower (75% vs 84%, p=0.01). A trend toward more procedural complications was observed in patients with BAO (32% vs 21%, p=0.075). The frequency of SICH was 2% vs 5% (p=0.25). At 3 months, patients with BAO had a lower rate of independence (mRS 0–2) (40% vs 58%, p=0.016) and higher mortality (33% vs 12%, p<0.001). The rate of futile recanalization was 50% in BAO versus 35% in anterior circulation occlusions (p=0.05). Age and duration of the procedure were significant predictors of futile recanalization in BAO. Conclusions MT is more laborious and shows more procedural complications in BAO than in anterior circulation strokes. The likelihood of futile recanalization is higher in BAO and is associated with greater age and longer procedure duration. A refinement of endovascular procedures for BAO might help optimize the results.
European Journal of Neurology | 2017
Jorge Rodríguez-Pardo; B. Fuentes; M. Alonso de Leciñana; Á. Ximénez-Carrillo; Gustavo Zapata-Wainberg; J. Álvarez‐Fraga; F. J. Barriga; L. Castillo; J. Carneado‐Ruiz; J. Díaz-Guzmán; J. Egido‐Herrero; A. Felipe; J. Fernández‐Ferro; L. Frade‐Pardo; Á. García‐Gallardo; A. García-Pastor; A. Gil-Núñez; C. Gómez‐Escalonilla; M. Guillán; Y. Herrero‐Infante; J. Masjuan‐Vallejo; M. Á. Ortega‐Casarrubios; José Vivancos-Mora; E. Díez-Tejedor
For patients with acute ischaemic stroke due to large‐vessel occlusion, it has recently been shown that mechanical thrombectomy (MT) with stent retrievers is better than medical treatment alone. However, few hospitals can provide MT 24 h/day 365 days/year, and it remains unclear whether selected patients with acute stroke should be directly transferred to the nearest MT‐providing hospital to prevent treatment delays. Clinical scales such as Rapid Arterial Occlusion Evaluation (RACE) have been developed to predict large‐vessel occlusion at a pre‐hospital level, but their predictive value for MT is low. We propose new criteria to identify patients eligible for MT, with higher accuracy.
Journal of NeuroInterventional Surgery | 2017
Gustavo Zapata-Wainberg; Á. Ximénez-Carrillo; Santiago Trillo; Blanca Fuentes; Antonio Cruz-Culebras; Clara Aguirre; María Alonso de Leciñana; Rocío Vera; Eduardo Bárcena; Andrés Fernández-Prieto; José Carlos Méndez-Cendón; J.L. Caniego; Exuperio Díez-Tejedor; J. Masjuan; J. Vivancos
Background and purpose To investigate the efficacy and safety of mechanical thrombectomy in patients with acute ischemic stroke according to the oral anticoagulation medication taken at the time of stroke onset. Materials and methods A retrospective multicenter study of prospectively collected data based on data from the registry the Madrid Stroke Network was performed. We included consecutive patients with acute ischemic stroke treated with mechanical thrombectomy and compared the frequency of intracranial hemorrhage and the modified Rankin Scale (mRS) score at 3 months according to anticoagulation status. Results The study population comprised 502 patients, of whom 389 (77.5%) were not anticoagulated, 104 (20.7%) were taking vitamin K antagonists, and 9 (1.8%) were taking direct oral anticoagulants. Intravenous thrombolysis had been performed in 59.8% and 15.0% of non-anticoagulated and anticoagulated patients, respectively. Rates of intracranial hemorrhage after treatment were similar between non-anticoagulated and anticoagulated patients, as were rates of recanalization. After 3 months of follow-up, the mRS score was ≤2 in 56.3% and 55.7% of non-anticoagulated and anticoagulated patients, respectively (P=NS). Mortality rates were similar in the two groups (13.1%and12.4%, respectively). Among anticoagulated patients, no differences were found for intracranial bleeding, mRS score, or mortality rates between patients taking vitamin K antagonists and those taking direct oral anticoagulants. Conclusions Mechanical thrombectomy is feasible in anticoagulated patients with acute ischemic stroke. The outcomes and safety profile are similar to those of patients with no prior anticoagulation therapy.
International Journal of Stroke | 2017
A. García-Pastor; Antonio Gil-Núñez; José María Ramírez-Moreno; Noelia González-Nafría; J. Tejada; Francisco Moniche; Portilla-Cuenca Jc; P. Martínez-Sánchez; B. Fuentes; Miguel Ángel Gamero-García; María Alonso de Leciñana; David Cánovas-Verge; Yolanda Aladro; Vera Parkhutik; Aida Lago-Martín; Ana María de Arce-Borda; María Usero-Ruíz; Raquel Delgado-Mederos; Ana Pampliega; Á. Ximénez-Carrillo; Mónica Bártulos-Iglesias; Enrique Castro-Reyes
Background The risk of recurrent stroke among patients with symptomatic carotid near-occlusion is not well established, and management of the condition remains controversial. Symptomatic carotid near-occlusion with full collapse has been identified as a strong predictor of early recurrence. We aimed to analyze the 90-day risk of recurrent ipsilateral ischemic stroke in medically treated patients with symptomatic carotid near-occlusion. Methods We performed a multicenter, nationwide, prospective study from January 2010 to May 2016. Patients with angiography-confirmed symptomatic carotid near-occlusion were included. The primary endpoint was ipsilateral ischemic stroke or transient ischemic attack (TIA) within 90 days after the presenting event. For this analysis, patients who underwent revascularization within 90 days after stroke were excluded. Results The study population comprised 141 patients from 17 Spanish centers; 83 patients were treated medically. Primary endpoint occurred in eight patients, resulting in a cumulative rate of 10.6% (95% CI, 3.7–17.5). Previous history of stroke or transient ischemic attack was identified as an independent predictor for recurrence in the multivariate Cox regression analysis (HR, 4.37 [95% CI, 1.05–18.18]; p = 0.043), while the presence of full collapse was not associated with an increased risk (HR, 0.81 [95% CI, 0.17–3.92]; p = 0.793). The risk of recurrence was also not affected by the presence of significant stenosis or occlusion of the contralateral carotid artery, or by the collateral circulation. Conclusions Patients with symptomatic carotid near-occlusion seem to have an increased risk of early ipsilateral recurrent stroke. Our results contrast with the low risk of symptomatic carotid near-occlusion reported to date. Full collapse did not increase the risk of recurrent stroke in our study.
Cephalalgia | 2018
Sonia Quintas; Rocío López Ruiz; Santiago Trillo; Ana Beatriz Gago-Veiga; Gustavo Zapata-Wainberg; Julio Dotor García-Soto; Á. Ximénez-Carrillo; J. Vivancos
Introduction The syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL) may mimic stroke when patients present with acute/subacute focal neurological deficits. It would be helpful to identify investigations that assist the neurologist in differentiating between HaNDL and stroke. Case reports We describe three cases that proved to be HaNDL, but were initially considered to be strokes. Hypoperfusion was noted in the CT perfusion (CTP) studies in all three cases, which extended beyond any single cerebral arterial supply. The CTP findings suggested a stroke mimic, and there was no improvement on thrombolysis. MRI failed to show any abnormalities in diffusion and EEGs showed non-epileptiform changes. Lumbar punctures demonstrated a lymphocytic pleocytosis. Conclusion The diagnosis of HaNDL is based on clinical and CSF criteria, but neuroimaging, including CT perfusion, can be helpful in differentiating the clinical syndrome from stroke.
Neurologia | 2014
J. Vivancos; F. Gilo; R. Frutos; J. Maestre; A. García-Pastor; F. Quintana; Á. Ximénez-Carrillo
Neurologia | 2014
J. Vivancos; F. Gilo; R. Frutos; J. Maestre; A. García-Pastor; F. Quintana; J.M. Roda; Á. Ximénez-Carrillo; E. Díez Tejedor; B. Fuentes; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; Mar Castellanos; José Castillo; A. Dávalos; F. Díaz-Otero; J.A. Egido; J.C. Fernández; M. Freijo; J. Gállego; A. Gil-Núñez; Pablo Irimia; Aida Lago; J. Masjuan; Joan Martí-Fàbregas; P. Martínez-Sánchez; Eduardo Martínez-Vila